博瑞医药 (688166.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(博瑞医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 327,395,843.03282,544,604.16304,937,396.25245,010,132.58271,971,006.83251,977,129.87248,373,219.05
 营业收入(元) 327,395,843.03282,544,604.16304,937,396.25245,010,132.58271,971,006.83251,977,129.87248,373,219.05
二、营业总成本(元) 236,664,603.64233,731,900.39229,202,715.92218,635,577.49180,355,532.54202,896,285.00181,443,131.76
 营业成本(元) 120,596,504.12132,948,500.26125,394,155.3986,692,565.5799,229,764.3899,909,645.2790,466,753.08
 研发费用(元) 60,427,215.8954,730,136.1848,657,672.0967,971,575.1445,204,654.1351,110,909.5942,737,799.16
 营业税金及附加(元) 1,553,641.351,472,068.551,394,873.411,904,991.781,620,194.561,122,469.26575,801.80
 销售费用(元) 16,687,890.4111,859,570.8716,556,510.149,826,518.7113,948,895.0129,827,503.3516,490,746.07
 管理费用(元) 31,297,228.2423,530,988.9428,280,327.1037,727,752.8827,559,145.3126,312,879.4623,290,192.83
 财务费用(元) 6,102,123.639,190,635.598,919,177.7914,512,173.41-7,207,120.85-5,387,121.937,881,838.82
  其中:利息费用(元) 9,631,421.4113,245,567.8910,691,270.0213,050,815.902,741,793.79-1,839,129.189,756,887.04
  其中:利息收入(元) 2,952,245.944,458,608.112,987,243.42950,842.64601,915.86-631,082.511,317,100.93
 资产减值损失(元) ----7,498,961.16---
 信用减值损失(元) -3,103,468.87-4,028,719.67250,038.084,167,267.001,861,450.22-3,365,672.12-1,290,012.67
三、其他经营收益
 加:公允价值变动收益(元) -1,487,045.661,407,761.76334,714.50-770,374.81-6,176,591.353,813,123.35-260,798.00
 加:投资收益(元) -3,431,280.14-3,254,076.39-1,552,441.38-5,251,848.81-1,154,965.1410,999,286.59-635,557.27
  其中:对联营企业和合营企业的投资收益(元) -2,851,808.40---4,332,030.68-1,470,448.02--
 其他收益(元) 1,703,387.683,112,554.76838,629.2612,910,594.605,233,779.872,169,788.55543,668.29
四、营业利润(元) 84,412,832.4037,938,004.0975,605,620.7929,941,117.8191,379,147.8955,547,562.1865,287,387.64
 加:营业外收入(元) 183,239.4911,368.341.76-26,058.98222,769.54827,040.0527,265.88
 减:营业外支出(元) 184,365.10--205,475.86346,214.46432,220.4415,100.00
五、利润总额(元) 84,411,706.7937,670,959.1875,605,622.5529,709,582.9791,255,702.9755,942,381.7965,299,553.52
 减:所得税费用(元) 6,060,556.165,326,026.709,561,010.79-3,838,694.3217,482,592.539,637,687.987,498,678.46
六、净利润(元) 78,351,150.6332,344,932.4866,044,611.7633,548,277.2973,773,110.4446,304,693.8157,800,875.06
(一)按经营持续性分类
  持续经营净利润(元) 78,351,150.6332,344,932.4866,044,611.7633,548,277.2973,773,110.4446,304,693.8157,800,875.06
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 82,350,373.2038,670,898.1070,769,470.4541,999,370.8585,622,530.0551,246,880.7160,754,391.10
  少数股东损益(元) -3,999,222.57-6,325,965.62-4,724,858.69-8,451,093.56-11,849,419.61-4,942,186.90-2,953,516.04
 扣除非经常性损益后的净利润(元) 82,732,282.6635,261,403.9869,711,194.9032,441,880.2386,260,922.4334,620,267.3660,315,257.52
七、每股收益
 一、基本每股收益(元) 0.190.090.170.100.210.120.15
 二、稀释每股收益(元) 0.190.090.170.100.210.120.15
八、其他综合收益(元) -851,613.21---34,416,266.56-691,753.87--
 归属于母公司股东的其他综合收益(元) -851,613.21---34,416,266.56-691,753.87--
九、综合收益总额(元) 77,499,537.4228,289,447.8166,044,611.76-867,989.2773,081,356.5747,208,195.3757,800,875.06
 归属于母公司所有者的综合收益总额(元) 81,498,759.9934,615,413.4370,769,470.457,583,104.2984,930,776.1852,150,382.2760,754,391.10
 归属于少数股东的综合收益总额(元) -3,999,222.57-6,325,965.62-4,724,858.69-8,451,093.56-11,849,419.61-4,942,186.90-2,953,516.04
公告日期 2023-10-272023-08-252023-04-252023-04-252022-10-282022-08-252022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院